ABCL logo

AbCellera Biologics Inc. (ABCL) Shareholders equity

annual shareholders equity:

$1.06B-$96.23M(-8.35%)
December 31, 2024

Summary

  • As of today (July 26, 2025), ABCL annual stockholders equity is $1.06 billion, with the most recent change of -$96.23 million (-8.35%) on December 31, 2024.
  • During the last 3 years, ABCL annual shareholders equity has risen by +$30.35 million (+2.96%).
  • ABCL annual shareholders equity is now -14.37% below its all-time high of $1.23 billion, reached on December 31, 2022.

Performance

ABCL Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

quarterly shareholders equity:

$1.02B-$33.10M(-3.13%)
March 31, 2025

Summary

  • As of today (July 26, 2025), ABCL quarterly stockholders equity is $1.02 billion, with the most recent change of -$33.10 million (-3.13%) on March 31, 2025.
  • Over the past year, ABCL quarterly shareholders equity has dropped by -$106.93 million (-9.46%).
  • ABCL quarterly shareholders equity is now -18.17% below its all-time high of $1.25 billion, reached on September 30, 2022.

Performance

ABCL quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ABCL Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-8.3%-9.5%
3 y3 years+3.0%-15.3%
5 y5 years+10000.0%-

ABCL Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-14.4%+3.0%-18.2%at low
5 y5-year-14.4%>+9999.0%-18.2%+1046.3%
alltimeall time-14.4%>+9999.0%-18.2%+9878.4%

ABCL Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$1.02B(-3.1%)
Dec 2024
$1.06B(-8.4%)
$1.06B(-2.0%)
Sep 2024
-
$1.08B(-3.0%)
Jun 2024
-
$1.11B(-1.7%)
Mar 2024
-
$1.13B(-1.9%)
Dec 2023
$1.15B(-6.6%)
$1.15B(-2.6%)
Sep 2023
-
$1.18B(-1.0%)
Jun 2023
-
$1.19B(-1.1%)
Mar 2023
-
$1.21B(-2.0%)
Dec 2022
$1.23B
$1.23B(-1.4%)
DateAnnualQuarterly
Sep 2022
-
$1.25B(+3.1%)
Jun 2022
-
$1.21B(+0.4%)
Mar 2022
-
$1.21B(+17.7%)
Dec 2021
$1.03B(+23.5%)
$1.03B(+7.6%)
Sep 2021
-
$953.40M(-1.5%)
Jun 2021
-
$967.68M(+1.1%)
Mar 2021
-
$957.12M(+15.2%)
Dec 2020
$830.51M(+8000.9%)
$830.51M(+830.7%)
Sep 2020
-
$89.24M(+770.4%)
Dec 2019
$10.25M(-11.7%)
$10.25M
Dec 2018
$11.61M
-

FAQ

  • What is AbCellera Biologics Inc. annual stockholders equity?
  • What is the all time high annual shareholders equity for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual shareholders equity year-on-year change?
  • What is AbCellera Biologics Inc. quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly shareholders equity year-on-year change?

What is AbCellera Biologics Inc. annual stockholders equity?

The current annual shareholders equity of ABCL is $1.06B

What is the all time high annual shareholders equity for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual stockholders equity is $1.23B

What is AbCellera Biologics Inc. annual shareholders equity year-on-year change?

Over the past year, ABCL annual stockholders equity has changed by -$96.23M (-8.35%)

What is AbCellera Biologics Inc. quarterly stockholders equity?

The current quarterly shareholders equity of ABCL is $1.02B

What is the all time high quarterly shareholders equity for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly stockholders equity is $1.25B

What is AbCellera Biologics Inc. quarterly shareholders equity year-on-year change?

Over the past year, ABCL quarterly stockholders equity has changed by -$106.93M (-9.46%)
On this page